Sarah Hoffmann MD, MSc

Dr. Hoffmann is a specialist at the neurology clinic and deputy head of the integrated myasthenia center at the Charité in Berlin. Dr. Hoffmann identified biomarkers with the deposition of components of the immune response - namely complement deposits and IgG1 antibodies - that facilitate the diagnosis and targeted treatment of this seronegative form.